Ross Emily
University of Sheffield.
Body Soc. 2024 Dec;30(4):31-56. doi: 10.1177/1357034X241286356. Epub 2024 Oct 28.
In cultures where reproduction is highly medicalised, pregnancy is often understood in terms of foetal development and an anticipated baby. This is connected to a wider privileging of the 'foetal subject' in these settings, which has had implications for reproductive autonomy. In this article, I disrupt dominant understandings of pregnancy by engaging with qualitative accounts of gestational trophoblastic disease. This rare condition can entail experiences of pregnancy without foetal development, allowing for scholarly attention to the wider biological, affective and relational constituents of this corporeal event. In this article, I pay particular attention to the 'pregnancy hormone' human chorionic gonadotropin (hCG), which in the context of gestational trophoblastic disease becomes a biomarker for disease. My research extends feminist science studies perspectives destabilising understandings of maternal and foetal bodies as bounded and distinct entities. The article de-centres foetal development as the most significant consequence of conception and enriches feminist discussions of reproductive politics.
在生殖高度医学化的文化中,怀孕通常根据胎儿发育和预期中的婴儿来理解。这与这些环境中对“胎儿主体”的更广泛重视相关联,这对生殖自主权产生了影响。在本文中,我通过参与对妊娠滋养细胞疾病的定性描述来打破对怀孕的主流理解。这种罕见病症可能带来没有胎儿发育的怀孕经历,从而使学术关注能够投向这一身体事件更广泛的生物学、情感和关系构成要素。在本文中,我特别关注“妊娠激素”人绒毛膜促性腺激素(hCG),在妊娠滋养细胞疾病的背景下,它成为疾病的生物标志物。我的研究扩展了女性主义科学研究的视角,动摇了将母体和胎儿身体视为有界且不同实体的理解。本文将胎儿发育从受孕的最重要结果这一中心位置移开,并丰富了女性主义对生殖政治的讨论。